PhotoMedex, Inc. (NASDAQ:PHMD) Files An 8-K Other EventsITEM 8.01 OTHER EVENTS
On September 28, 2017, PhotoMedex, Inc. (OTC QB, NASDAQCM and TASE “PHMD”, hereinafter referred to as the “Company”) issued a press release in which it announced that on September 28, 2017, the Company received formal notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”) had granted the Company’s request for the resumption of trading of the Company’s common stock on Nasdaq, which will take effect with the open of the market today, October 2, 2017.
The Listing Council’s determination to continue the Company’s listing on Nasdaq followed the Listing Council’s conclusion that the Nasdaq Hearings Panel (the “Panel”) erred when it determined to delist the Company’s securities from Nasdaq. As a result of the Panel’s decision, trading in the Company’s common stock was suspended on Nasdaq effective with the open of business on July 7, 2017, and the Company’s common stock has traded in the over-the-counter market since that time.
The full text of the press release is furnished as Exhibit 99.1 to this report.
Forward-Looking Statements
This Current Report on Form 8-K may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Investors are cautioned that there can be no assurance actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward looking statements include, but are not limited to, statements with respect to the plans, strategies and objectives of management for future operations; product development, extensions and marketing; and expectations, beliefs or assumptions underlying any of the foregoing. The important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to, changes in consumers’ spending habits and the marketability of certain products.Please refer to the risks detailed from time to time in the reports we file with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2016, as well as other filings on Form 10-Q and periodic filings on Form 8-K, for additional factors that could cause actual results to differ materially from those stated or implied by such forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
In accordance with General Instruction B.2 of Form 8-K, the information in this current report, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
(d) EXHIBITS.
99.1Press Release dated October 2, 2017 issued by PhotoMedex, Inc.
PHOTOMEDEX INC ExhibitEX-99.1 2 s107657_ex99-1.htm EXHIBOT 99.1 Exhibit 99.1 PhotoMedex Receives Positive Nasdaq Listing Determination; To Resume Trading on Nasdaq Today HORSHAM,…To view the full exhibit click here
About PhotoMedex, Inc. (NASDAQ:PHMD)
PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. It operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. It provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. Through its subsidiary, Radiancy, Inc., it offers home-use devices under no!no! brand for indications, including hair removal, acne treatment, skin rejuvenation and lower back pain. Its professional product line includes offerings for acne clearance, skin tightening, psoriasis care and hair removal. It is also engaged in the development, manufacture and sale of surgical products, including free-beam and contact laser systems for surgery.
